Actionnariat et activité des initiés pour HCW Biologics Inc. (HCWB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.01 |
| Capitalisation | $1M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-29 | Wong Hing C | P-Purchase | 23,210 | $60K |
| 2026-07-29 | Flowers Lee | P-Purchase | 7,736 | $20K |
| 2026-07-29 | GARRETT SCOTT T | P-Purchase | 7,736 | $20K |
| 2026-05-22 | Wong Hing C | P-Purchase | 113,879 | $160K |
| 2026-05-22 | Wong Hing C | P-Purchase | 113,879 | $146K |
| 2026-05-22 | GARRETT SCOTT T | P-Purchase | 177,936 | $250K |
| 2026-05-22 | GARRETT SCOTT T | P-Purchase | 177,936 | $228K |
| 2026-05-22 | Byam Rebecca | P-Purchase | 14,235 | $20K |
| 2026-05-22 | Byam Rebecca | P-Purchase | 14,235 | $18K |
| 2025-05-16 | Wong Hing C | P-Purchase | 8,054 | $60K |
Bilan (10 ans)
| Année | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Trésorerie | $7.4M | $8.5M | $11.7M | $22.3M | $3.6M | $4.7M | $2.0M |
| Placements à Court Terme | 0 | 0 | $25.0M | $9.7M | 0 | 0 | 0 |
| Créances | 0 | $2.5M | $133000 | $417695 | $1.5M | $582201 | $32175 |
| Stocks | 0 | 0 | 0 | $1.4M | 0 | 0 | 0 |
| Actifs Courants | $8.0M | $12.1M | $40.5M | $34.1M | $6.4M | $5.7M | $2.3M |
| Immobilisations Corporelles | $2.0M | $1.6M | $1.1M | $10.8M | $20.5M | $22.9M | $20.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $10.1M | $15.4M | $53.5M | $46.8M | $28.5M | $30.2M | $24.5M |
| Dettes Fournisseurs | $392331 | $155343 | $223664 | $1.2M | $6.2M | $22.3M | $13.1M |
| Dette à Court Terme | 0 | $567311 | 0 | 0 | 0 | $6.3M | $6.8M |
| Passifs Courants | $1.1M | $1.0M | $2.3M | $3.0M | $8.7M | $29.6M | $21.1M |
| Dette à Long Terme | 0 | 0 | 0 | $6.4M | $6.3M | $7.4M | 0 |
| Passifs Totaux | $1.1M | $1.0M | $2.3M | $9.4M | $15.1M | $37.0M | $21.8M |
| Réserves | -$9.7M | -$16.7M | -$30.6M | -$45.5M | -$70.5M | -$100.6M | -$108.5M |
| Capitaux Propres | $9.0M | $14.4M | $51.2M | $37.4M | $13.5M | -$6.8M | $2.8M |
| Dette Totale | 0 | $567311 | 0 | $6.4M | $6.3M | $13.7M | $6.8M |
| Dette Nette | -$7.4M | -$7.9M | -$36.7M | -$25.7M | $2.7M | $9.0M | $4.9M |
| Fonds de Roulement | $7.0M | $11.1M | $38.2M | $31.1M | -$2.3M | -$23.9M | -$18.8M |
Santé financière
| Dette / Capitaux propres | 0.88 |
| Ratio de liquidité | 0.06 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -8.57 |
Rentabilité
| Rentabilité des capitaux propres | -142.16% |
| Rentabilité du capital investi | -39.28% |
| Rentabilité des actifs | -18.39% |
| Marge brute | 95.91% |
| Marge opérationnelle | -91.57% |
| Marge nette | -73.22% |
Entreprises liées: ACXP · ADIL · APRE · APVO · BCDA · BCLI · CELZ
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de HCWB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions